Literature DB >> 33459886

Registry versus publication: discrepancy of primary outcomes and possible outcome reporting bias in child and adolescent mental health.

Nikolina Vrljičak Davidović1, Luka Komić2, Ivana Mešin2, Mihaela Kotarac2, Donald Okmažić2, Tomislav Franić2,3.   

Abstract

Outcome reporting bias is one of the fundamental forms of publication bias. It implies publishing only outcomes that have positive results. The aim of this observational study was to explore primary outcome discrepancies between registry of clinical trials and their corresponding publications, since these can indicate outcome reporting bias in child mental health. Data were extracted from completed interventional clinical trials from ClinicalTrial.gov registry and its Archive site. Trials were registered under "Behaviours and Mental Disorders" category, and conducted on underage participants (0-17 years). Their primary outcomes were compared to those published in publication which had a corresponding NCT number stated in the text. Sixteen percent of trials did not have the minimum information on primary outcome stated in the registry-neither the measure used nor the measurement time points; 38.9% of trials had the minimum information stated to describe primary outcome, while only 3.3% of trials had all the necessary elements stated in the registry. Most of the publication in our sample had positive results (66.4%). Half of the trials registered before completion had non-matching primary outcomes in the registry and publication; 85.4% of trials with non-matching outcomes indicated possible outcome reporting bias for some of the primary outcome. Middle-sized trials and industry-funded trials were related with higher quality of primary outcome registration. Industry funding was related with positive findings in publication. Non-industry funding proved to be the only significant predictor of discrepancy between registered and published primary outcomes, and possible outcome reporting bias. Journal impact factor was not related with any of the outcome measures. The main limitation of the study is that it primarily offers an insight into discrepancy of registered and published outcomes. The methodology does not imply an access to results of unpublished outcomes - therefore, it was not possible to determine the presence of the bias with sufficient certainty in large number of trials. Further research should be done with improved methodology and additional data.
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Outcome reporting bias; Primary outcome; Publication bias; Trial registration

Mesh:

Year:  2021        PMID: 33459886     DOI: 10.1007/s00787-020-01710-5

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  44 in total

Review 1.  Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations.

Authors:  Shannon M Smith; Anthony T Wang; Anthony Pereira; Daniel R Chang; Andrew McKeown; Kaitlin Greene; Michael C Rowbotham; Laurie B Burke; Paul Coplan; Ian Gilron; Sharon H Hertz; Nathaniel P Katz; Allison H Lin; Michael P McDermott; Elektra J Papadopoulos; Bob A Rappaport; Michael Sweeney; Dennis C Turk; Robert H Dworkin
Journal:  Pain       Date:  2013-08-17       Impact factor: 6.961

2.  Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology.

Authors:  Xiao-Qian Li; Ge-Liang Yang; Kun-Ming Tao; Hui-Qing Zhang; Qing-Hui Zhou; Chang-Quan Ling
Journal:  Scand J Gastroenterol       Date:  2013-10-16       Impact factor: 2.423

3.  Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.

Authors:  Annelieke M Roest; Peter de Jonge; Craig D Williams; Ymkje Anna de Vries; Robert A Schoevers; Erick H Turner
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

Review 4.  Transparency of outcome reporting and trial registration of randomized controlled trials in top psychosomatic and behavioral health journals: A systematic review.

Authors:  Katherine Milette; Michelle Roseman; Brett D Thombs
Journal:  J Psychosom Res       Date:  2010-12-15       Impact factor: 3.006

5.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

6.  Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.

Authors:  Ludovic Trinquart; Adeline Abbé; Philippe Ravaud
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

7.  Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.

Authors:  Erick H Turner; Daniel Knoepflmacher; Lee Shapley
Journal:  PLoS Med       Date:  2012-03-20       Impact factor: 11.069

Review 8.  Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials.

Authors:  Ellen Driessen; Steven D Hollon; Claudi L H Bockting; Pim Cuijpers; Erick H Turner
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

9.  Why prudence is needed when interpreting articles reporting clinical trial results in mental health.

Authors:  Rafael Dal-Ré; Julio Bobes; Pim Cuijpers
Journal:  Trials       Date:  2017-03-28       Impact factor: 2.279

Review 10.  Systematic review: Outcome reporting bias is a problem in high impact factor neurology journals.

Authors:  Benjamin Howard; Jared T Scott; Mark Blubaugh; Brie Roepke; Caleb Scheckel; Matt Vassar
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.